医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Updated Prostate Cancer Risk Groups by Prostate-specific Membrane Antigen Positron Emission Tomography Prostate Cancer Molecular Imaging Standardized Evaluation (PPP2): Results from an International Multicentre Registry Study.

广告
第一作者: Madeleine J,Karpinski
第一单位: Department of Nuclear Medicine, DKTK and NCT University Hospital Essen, Essen, Germany; Department of Nuclear Medicine, University Hospital Münster, Münster, Germany. Electronic address: madeleine.karpinski@uk-essen.de.
作者单位: Department of Nuclear Medicine, DKTK and NCT University Hospital Essen, Essen, Germany; Department of Nuclear Medicine, University Hospital Münster, Münster, Germany. Electronic address: madeleine.karpinski@uk-essen.de. [1] Department of Nuclear Medicine, University Hospital Münster, Münster, Germany. [2] Department of Urology, University Hospital Münster, Münster, Germany. [3] Department of Nuclear Medicine, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany. [4] Department of Translational Imaging in Oncology, National Center for Tumour Diseases (NCT/UCC) Dresden: Faculty of Medicine and University Hospital Carl Gustav Carus, University of Technology Dresden (TUD), Dresden, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany. [5] Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University Vienna, Vienna, Austria. [6] Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Collegium Medicum - Faculty of Medicine, WSB University, Dąbrowa Górnicza, Poland. [7] Nuclear Medicine, Department of Health Sciences (DISSAL), University of Genova, Genova, Italy. [8] Nuclear Medicine, Department of Health Sciences (DISSAL), University of Genova, Genova, Italy; IRCCS Ospedale Policlinico San Martino, Genova, Italy. [9] Nuclear Medicine, University of Augsburg, Augsburg, Germany. [10] Department of Nuclear Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany. [11] Nuclear medicine, University Hospitals Leuven, KU Leuven, Leuven, Belgium. [12] Institute of Medical Informatics, Biometry and Epidemiology, University Hospital Essen, Essen, Germany. [13] Department of Urology, University Hospital Essen, Essen, Germany. [14] Department of Nuclear Medicine, DKTK and NCT University Hospital Essen, Essen, Germany. [15] Department of Radiotherapy, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. [16] The Russell H. Morgan Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. [17] Cancer Registry North-Rhine Westphalia, Bochum, Germany. [18] Ahmanson Translational Theranostics Division, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. [19] Sir Peter MacCallum Department of Oncology and Department of Medicine, University of Melbourne, Melbourne, Australia; Peter MacCallum Cancer Centre, Melbourne, Australia. [20] Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA. [21] Department of Nuclear Medicine, University Hospital Ulm, Ulm, Germany; Department of Radiology, University Hospital Ulm, Ulm, Germany. [22] Department of Urology, St Antonius Ziekenhuis, Nieuwegein/Utrecht, The Netherlands; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands. [23] Nuclear Medicine, Alma Mater Studiorum, University of Bologna, Bologna, Italy. [24] Nuclear Medicine, IRCCS, Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy. [25] Department of Translational Medicine, Lund University, Malmö, Sweden; Department of Urology, Skåne University Hospital, Malmö, Sweden. [26] Department of Translational Medicine, Lund University, Malmö, Sweden; Clinical Physiology and Nuclear Medicine, Skåne University Hospital, Malmö, Sweden. [27] Ahmanson Translational Theranostics Division, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany; Bavaria Cancer Research Centre (BZKF), Partner Site Munich, Munich, Germany. [28] Ahmanson Translational Theranostics Division, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany. [29] Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany. [30] Department of Nuclear Medicine, School of Medicine and Health, Klinikum Rechts der Isar, Technical University Munich, Munich, Germany. [31] Bavaria Cancer Research Centre (BZKF), Partner Site Munich, Munich, Germany; Department of Nuclear Medicine, School of Medicine and Health, Klinikum Rechts der Isar, Technical University Munich, Munich, Germany. [32]
DOI 10.1016/j.eururo.2025.04.017
PMID 40318933
发布时间 2025-11-20
提交
  • 浏览2
European urology

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷